News

ASPR’s Biomedical Advanced Research and Development Authority (BARDA) will provide up to a total of $38 million over the next 23 months to support development as well as

The DREAM Challenge is an open innovation non-profit biology project in which scientists share ideas and data. AstraZeneca’s move is aimed at advancing research into combination cancer therapy

The new biotechnology, dubbed the Cybercyte, is designed to cut in half the time and money required for preclinical trials. Cytocybernetics claims that the new technology could rapidly

The company will use the grant to discover preclinical DUB inhibitors directed at specific deubiquitylating enzymes (DUBs), which are involved in several cellular processes, including DNA damage and

The test uses real-time PCR technology for identifying and separating influenza A virus and influenza B virus RNA in 20 minutes. Highly conserved regions of the influenza A

The Johnson & Johnson Innovation Centre in London facilitated the research agreement. Under terms of the agreement, Nextera will, with use of its unique technology platform, undertake certain

The companies will start a managed access program in selected countries for NP001, Neuraltus’ investigational therapy for ALS. Coverage is planned to be expanded in the next year.

Intuniv, a drug for the treatment of ADHD in children and adolescents from 6 to 17 years old, is already licensed in the US and Canada. Shire said

Last year, Sun Pharma acquired Ranbaxy Laboratories in an all-stock transaction totalling equity value of $3.2bn. However, earlier this year Sun Pharma said as a part of the